GLPwatch
Papers (9189)
Page 142 of 154, ranked by citation count.
- Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection.
- Cost-effectiveness analysis of oral semaglutide versus subcutaneous dulaglutide in patients with type 2 diabetes mellitus: A Markov model study.
- Cost-Effectiveness of Highly Effective Glucose-Lowering Agents: Do Current Practices Optimize Clinical and Economic Outcomes?
- Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence.
- Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study by obesity and cardiovascular disease status.
- Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials.
- Liraglutide versus colesevelam for treating bile acid diarrhoea - Authors' reply.
- Bariatric Surgery in the Era of GLP1RA: A Narrative Review.
- 68 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas.
- Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.
- Development of novel radioiodinated exendin-4 derivatives targeting GLP-1 receptor for detection of β-cell mass.
- Semaglutide in heart failure and atherosclerotic cardiovascular disease: the current state-of-the-art.
- [Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?]
- Chemoenzymatic Synthesis of Rhamnolipid-Modified Exendin-4: A Dual Approach for Long-Acting Glycemic Control through Endogenous Antibody Recruitment and Albumin Interaction.
- Morphology-driven zinc oxide biointeractive carriers with biological barrier modulating effects for pulmonary delivery of liraglutide.
- Semaglutide: An emerging treatment option for patients with obesity related HFpEF.
- Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
- [Weight reduction with incretin mimetics-Opportunities and risks].
- Will oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide?
- Adultes en surpoids ou obèses : effets du sémaglutide.
- [Obesity treatment with semaglutide].
- Neuropsychiatric side effects of semaglutide in patients with dementia.
- Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute Cholelithiasis.
- Liraglutide alters gut microbiota and improves endothelium-dependent relaxation in db/db mice.
- [Does a higher dose of oral semaglutide treatment make sense?]
- Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications.
- Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial.
- Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists: A systematic review.
- Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review.
- In brief: Higher-dose semaglutide (Ozempic) for type 2 diabetes.
- Predictors and Characteristics of Hair Loss Among Users of GLP-1 Receptor Agonists: A Cross-Sectional Analysis.
- GLP-1 receptor agonists and alcohol use disorder: a systematic review.
- GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.
- Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes.
- Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis.
- Semaglutide may reduce cardiovascular disease and heart failure.
- Carnitine Deficiency Caused by Salcaprozic Acid Sodium Contained in Oral Semaglutide in a Patient with Multiple Acyl-CoA Dehydrogenase Deficiency.
- Association of semaglutide use with outcomes in chronic plantar heel pain: a prospective observational cohort and a pilot interventional study.
- Compounded incretins in clinical practice: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy.
- Semaglutide Overdose in a Diabetic Patient: Suicidal Behavior and Multiorgan Failure.
- RYGB induces vagal sensory neuropathy characterized by altered Glp1r expression and enhanced exendin-4 responsiveness in male mice.
- Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A Bibliometric and Evidence-Based Review.
- Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison.
- [Effects of Exendin-4 on the differentiation of neural stem cells from subventricular zone of adult mice in vitro].
- [Effect of semaglutide treatment on the body weight and the glucose, insulin and thyroid hormone levels in aging rats with diet-induced obesity.]
- In patients ≥ 50 years with type 2 diabetes and CV disease or risk factors, oral semaglutide did not increase CV events.
- Liraglutide Nano-Preparation on Perioperative Neurocognitive Dysfunction in Aged Mice.
- Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients.
- [Liraglutide].
- Effect of liraglutide treatment on mitigation of hearing damage induced by multiday repeated high-intensity blasts.
- In Silico Exploration of Therapeutics for GLP-1 Receptor Agonist-Induced Nausea and Their in Vivo Validation in Mice.
- Effects of tryptophan-selective lipidated glucagon-like peptide 1 (GLP-1) peptides on the GLP-1 receptor.
- Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide.
- Glucagon-like peptide-1 receptor (GLP-1R) agonists prevent tributyltin-induced muscle atrophy/wasting via restoring GLP-1R signaling in vitro and in mice.
- Muscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational study.
- Assessing the Oncological Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
- [Is there life after teduglutide?]
- Single-dose pharmacokinetics of sublingual semaglutide in rats.
- National trends in prescription drug expenditures and projections for 2026.
- Dynamic structural analysis-based epitope prediction of Exendin-4 in aqueous solution.